Novo Nordisk
NVO
#105
Rank
โ‚น17.294 T
Marketcap
โ‚น3,923
Share price
2.41%
Change (1 day)
-10.15%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Earnings for Novo Nordisk (NVO)

Earnings in 2026 (TTM): โ‚น2.144 Trillion

According to Novo Nordisk's latest financial reports the company's current earnings are โ‚น51.43 Billion. In 2025 the company made an earning of โ‚น1.975 Trillion, an increase over its 2024 earnings that were of โ‚น1.858 Trillion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novo Nordisk from 1984 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚น2.144 T8.58%
2025 โ‚น1.975 T6.28%
2024 โ‚น1.858 T28.01%
2023 โ‚น1.451 T57.81%
2022 โ‚น920.07 B5.24%
2021 โ‚น874.29 B12.38%
2020 โ‚น777.96 B13.11%
2019 โ‚น687.80 B-3.45%
2018 โ‚น712.37 B1.88%
2017 โ‚น699.21 B4.3%
2016 โ‚น670.36 B10.32%
2015 โ‚น607.64 B7.47%
2014 โ‚น565.42 B3.4%
2013 โ‚น546.82 B19.09%
2012 โ‚น459.18 B15.58%
2011 โ‚น397.29 B16.58%
2010 โ‚น340.80 B25.66%
2009 โ‚น271.21 B10.68%
2008 โ‚น245.05 B55.82%
2007 โ‚น157.26 B7.02%
2006 โ‚น146.94 B19.05%
2005 โ‚น123.43 B10.55%
2004 โ‚น111.65 B
2002 โ‚น73.86 B-14.39%
2001 โ‚น86.28 B-52.82%
2000 โ‚น182.86 B250%
1999 โ‚น52.24 B31.21%
1998 โ‚น39.81 B34.31%
1997 โ‚น29.64 B11.46%
1996 โ‚น26.59 B9.03%
1995 โ‚น24.39 B-3.15%
1994 โ‚น25.18 B-0.67%
1993 โ‚น25.35 B45.38%
1992 โ‚น17.44 B-13.81%
1991 โ‚น20.23 B37.12%
1990 โ‚น14.75 B-0.79%
1989 โ‚น14.87 B26.2%
1988 โ‚น11.78 B24.97%
1987 โ‚น9.43 B-0.9%
1986 โ‚น9.51 B-7.78%
1985 โ‚น10.32 B24.87%
1984 โ‚น8.26 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
โ‚น656.66 B-69.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น3.276 T 51.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น733.94 B-66.12%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
โ‚น1.067 T-50.70%๐Ÿ‡บ๐Ÿ‡ธ USA